Pursuant to Rule 477 of Regulation C under the
Securities Act of 1933, as amended (the “Act”), 4DMed, Ltd., a Nevada corporation (the
“Company”)
hereby requests that the U.S. Securities and Exchange Commission
(the “Commission”)
consent to the withdrawal of the Company’s Registration
Statement (File No. 333-241060) on Form S-1 filed with the
Commission on August 6, 2020 (the “Registration
Statement”), with such
application to be approved effective as of the date hereof or at
the earliest practical date thereafter.
The
Company submits this request for withdrawal as it does not intend
to pursue the contemplated public offering at this time and
believes the withdrawal to be consistent with the public interest
and the protection of investors as contemplated by paragraph
(a) of Rule 477 of the Act. Since the Registration Statement
was not declared effective by the Commission, no sales of the
Company’s common stock were made pursuant to the Registration
Statement.
If
you have any questions, please contact our legal counsel Paul Camp
Lane, Lane & Associates at (407) 325-3017.
Sincerely,
By: /s/
Yuen May Cheung
Name:
Yuen May Cheung
Title:
President
Dates Referenced Herein and Documents Incorporated by Reference
